Clinical Trials on Prophylaxis of Lyme Borreliosis
Total 62 results
-
Baxalta now part of ShireBaxter Innovations GmbHCompleted
-
Sorlandet Hospital HFSouth-Eastern Norway Regional Health AuthorityCompleted
-
PfizerValneva Austria GmbHCompletedLyme Borreliosis, Nervous SystemBelgium, United States
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingPhysical Activity | Lyme Borreliosis | Lyme Borreliosis, Nervous SystemFrance
-
PfizerValneva Austria GmbHActive, not recruitingLyme BorreliosisUnited States
-
PfizerValneva Austria GmbHCompletedLyme BorreliosisUnited States
-
PfizerCompletedLyme BorreliosisUnited States, Germany, Belgium
-
Lyme Diagnostics Ltd.Pharmahungary GroupCompletedLyme BorreliosisAustria, Czechia, Germany, Hungary, Poland, Slovakia
-
University Hospital, Strasbourg, FranceRecruitingLyme BorreliosisFrance
-
University Medical Centre LjubljanaUnknown
-
University Hospital, Strasbourg, FranceSociété de Dermatologie FrançaiseActive, not recruiting
-
University Medical Centre LjubljanaCompleted
-
Roxane LaboratoriesCompletedProphylaxis of Organ RejectionUnited States
-
Roxane LaboratoriesCompletedProphylaxis of Organ RejectionUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
Morten LindbaekNorwegian Institute of Public Health; Sorlandet Hospital HF; Norwegian University...CompletedLyme Disease | Erythema Migrans | Erythema Chronicum Migrans | Borreliosis | Early Lyme DiseaseNorway
-
Duke UniversityOrthopedic Research and Education Foundation; American Association of Hip and...RecruitingArthropathy of Knee | Antibiotic ProphylaxisUnited States
-
Hopital Nord Franche-ComteCompletedQuality of Life | Neuroborreliosis, LymeFrance
-
Roxane LaboratoriesCompletedProphylaxis of Organ RejectionUnited States
-
Roxane LaboratoriesCompletedProphylaxis of Organ RejectionUnited States
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
-
Kasey PhiferTerminatedLyme Disease | Lyme Arthritis | Lyme Neuroborreliosis | Unknown Origin FeverUnited Kingdom
-
Novartis PharmaceuticalsCompletedProphilaxis of Acute Rejection in Patients Receiving a Renal AllograftSpain
-
Simon GregsonNational Institute of Mental Health (NIMH); University of Copenhagen; London... and other collaboratorsCompletedImproving Perceptions of HIV Risk | Improving Uptake of Pre-exposure Prophylaxis for HIVZimbabwe
-
ThromboGenicsBioInvent International ABCompletedProphylaxis of Venous Thromboembolic EventsAustria, Netherlands, Belgium, Bulgaria, Hungary, Latvia, Poland, Russian Federation, Ukraine
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingTo Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
-
MinaPharm PharmaceuticalsRecruitingProphylaxis of Deep Vein ThrombosisEgypt
-
Medical University of GdanskBaxter Healthcare CorporationUnknownAssessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant ProphylaxisPoland
-
UPECLIN HC FM Botucatu UnespCompletedProphylaxis of Deep Vein ThrombosisBrazil
-
Napo Pharmaceuticals, Inc.Active, not recruitingAdult Solid Tumor | Cancer Therapy-Related Diarrhea | Chemotherapy-related Diarrhea | Prophylaxis of Diarrhea | Symptomatic Relief of Diarrhea | Targeted Therapy-related DiarrheaUnited States, Taiwan, Georgia, Serbia, Argentina
-
University of UtahCompletedProphylaxis of Acute Mountain SicknessUnited States
-
BayerCompletedTreatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer PatientsUnited States
-
University Hospital Inselspital, BerneUniversity of Lausanne HospitalsCompletedProphylaxis of Venous ThromboembolismSwitzerland
-
University Hospital Inselspital, BerneBayer; Centre Hospitalier Universitaire VaudoisCompleted
-
PfizerEuropean Society for Blood and Marrow TransplantationCompletedProphylaxis Of Invasive Fungal InfectionsPortugal, Belgium, France, Germany, Spain, United Kingdom, Switzerland, Sweden
-
SanofiTerminatedThrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)Hungary
-
Ology BioservicesCompletedProphylaxis of Ross River Virus InfectionAustralia
-
PfizerCompletedAntifungal Prophylaxis of Invasive Fungal InfectionsCanada, Spain, Greece, France, Portugal, United Kingdom, Czech Republic, Egypt, Jordan, Russian Federation, Switzerland, Turkey
-
Ology BioservicesCompleted
-
Abbott BiologicalsCompletedProphylaxis of InfluenzaGermany
-
Shahid Beheshti University of Medical SciencesCompletedEndophthalmitis | Prophylaxy of Post Traumatic Endophthalmitis | Bacterial EndophthalmitisIran, Islamic Republic of
-
Novartis VaccinesCompleted
-
Research Foundation for Mental Hygiene, Inc.FDC FoundationCompletedQuality of Life | FatigueUnited States
-
Medical University InnsbruckCompletedAchievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin ResistanceAustria
-
Novartis VaccinesCompletedProphylaxis of Avian InfluenzaFinland
-
Novartis VaccinesCompletedProphylaxis of Avian Influenza VaccineUnited Kingdom
-
BayerRecruitingHemophilia A | Prophylaxis of Bleeding | Treatment of BleedingKorea, Republic of
-
BayerActive, not recruitingHemophilia A | Children | Prophylaxis of Bleeding | Treatment of BleedingCanada, United States, Brazil, Italy, Turkey, Argentina, Norway
-
University Of PerugiaUnknownThe Primary Study Objective is to Assess the Efficacy and | Safety of Extended 4-week Heparin Prophylaxis Compared to | Prophylaxis Given for 8±2 Days After Planned Laparoscopic | Surgery for Colorectal Cancer. | The Clinical Benefit Will be Evaluated as the Difference in | the Incidence of... and other conditionsItaly
-
BayerRecruitingHemophilia A | Prophylaxis of BleedingUnited States